<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-01-19">January 19, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Sabine</forename><surname>Westphal</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Aleixandria</forename><surname>Mcgeary</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sandra</forename><surname>Rudloff</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Andrea</forename><surname>Wilke</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">Olaf</forename><surname>Penack</surname></persName>
							<email>olaf.penack@charite.de</email>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Consuelo</surname></persName>
						</author>
						<author>
							<persName><roleName>Hospital</roleName><forename type="first">Del</forename><surname>Cañizo</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Department of Hematology, Oncology and Tumorimmunology</orgName>
								<orgName type="institution">Charite ´Campus Virchow</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Universitario de Salamanca</orgName>
								<address>
									<country key="ES">SPAIN</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The Green Tea Catechin Epigallocatechin Gallate Ameliorates Graft-versus-Host Disease</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-01-19">January 19, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">903D7F197DD3CF652A08A49B84D22FC0</idno>
					<idno type="DOI">10.1371/journal.pone.0169630</idno>
					<note type="submission">Received: May 4, 2016 Accepted: December 9, 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:22+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Allogeneic hematopoetic stem cell transplantation (allo-HSCT) is a standard treatment for leukemia and other hematologic malignancies.</s><s>The major complication of allo-HSCT is graft-versus-host-disease (GVHD), a progressive inflammatory illness characterized by donor immune cells attacking the organs of the recipient.</s><s>Current GVHD prevention and treatment strategies use immune suppressive drugs and/or anti-T cell reagents these can lead to increased risk of infections and tumor relapse.</s><s>Recent research demonstrated that epigallocatechin gallate (EGCG), a component found in green tea leaves at a level of 25-35% at dry weight, may be useful in the inhibition of GVHD due to its immune modulatory, anti-oxidative and anti-angiogenic capacities.</s><s>In murine allo-HSCT recipients treated with EGCG, we found significantly reduced GVHD scores, reduced target organ GVHD and improved survival.</s><s>EGCG treated allo-HSCT recipients had significantly higher numbers of regulatory T cells in GVHD target organs and in the blood.</s><s>Furthermore, EGCG treatment resulted in diminished oxidative stress indicated by significant changes of glutathione blood levels as well as glutathione peroxidase in the colon.</s><s>In summary, our study provides novel evidence demonstrating that EGCG ameliorates lethal GVHD and reduces GVHD-related target organ damage.</s><s>Possible mechanisms are increased regulatory T cell numbers and reduced oxidative stress.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is the only curative treatment option for many patients suffering from leukemia and other hematological malignancies.</s><s>Unfortunately, many patients die after allo-HSCT due to graft-versus-host disease (GVHD), a progressive inflammatory disease.</s><s>GVHD is an immunological reaction of donor cells against the recipient, mainly driven by donor T cells.</s><s>Typical target organs involved in GVHD are the skin, the liver and the gut, where donor T cells induce severe damages of the organs resulting in consecutive loss of organ function.</s></p><p><s>Standard prophylaxis and therapy of GVHD are immunosuppressive drugs with profound inhibitory effects on allogeneic T cells.</s><s>The disadvantages of using immunosuppressive drugs after allo-HSCT is an increased risk of potentially life threatening infects and unwanted suppression of anti-tumor effects (graft-versus-tumor, GVT).</s><s>Therefore, there is a medical need for new therapeutic approaches against GVHD.</s></p><p><s>Epigallocatechin gallate (EGCG) is a polyphenol which is found in high concentration in the dry leaves of green and white tea and, in smaller quantity, in black tea.</s><s><ref type="bibr" target="#b0">[1]</ref> We became interested in investigating EGCG during GVHD because of our recent results on successful prevention of tissue damage by ECGC in a murine model of colitis.</s><s><ref type="bibr" target="#b1">[2]</ref> EGCG has several in vivo effects, these include three main mechanisms of how it could potentially reduce GVHD.</s><s><ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b4">[5]</ref> First, GVHD is associated with reduced regulatory T cell numbers in target organs and adoptive therapy of regulatory T cells can be used to prevent GVHD.</s><s><ref type="bibr" target="#b5">[6]</ref> Several reports indicate that EGCG attenuate inflammatory diseases like arthritis and experimental autoimmune encephalomyelitis (EAE) by its influence on regulatory T cells.</s><s><ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b7">8]</ref> Second, GVHD and tumor growth are associated with neovascularization and the inhibition of neovascularization has been used therapeutically to improve patient survival after allo-HSCT.</s><s><ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref> It has been demonstrated that EGCG inhibits neovascularization in different cancers <ref type="bibr" target="#b10">[11]</ref> and inflammatory diseases.</s><s><ref type="bibr" target="#b11">[12]</ref> Third, GVHD is associated with high levels of reactive oxygen species (ROS) <ref type="bibr" target="#b12">[13]</ref> and the reduction of ROS is recognized as a therapeutic principle to reduce inflammation.</s><s><ref type="bibr" target="#b13">[14]</ref> It was shown that EGCG reduces the amount of ROS in inflammatory diseases, such as in an inflammatory model in human corneal epithelial cells.</s><s><ref type="bibr" target="#b14">[15]</ref> The objective of the present study was to test our hypothesis that EGCG is useful in ameliorating GVHD.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods Mice</head><p><s>Female C57BL7/6 mice, female B6D2F1 mine and female and male LP/J mice were purchased from Charles River Laboratories (Sulzfeld,Germany).</s><s>Animals were 10-12 weeks old and had at least a weight of 23 g.</s><s>Mice housed in the Charite ´University Hospital Animal Facility under pathogen-free controlled conditions and 12hr-light/dark cycle.</s><s>Mice received normal chow and autoclaved hyperchlorinated drinking water.</s><s>All experiments were approved by the Regional Ethics Committee for Animal Research (State Office of Health and Social Affairs Berlin, Permit number G0414/09).</s><s>All efforts were made to minimize suffering.</s><s>For all experiments, mice were monitored daily.</s><s>Mice were individually scored twice a week for five clinical parameters (posture, activity, fur, skin and weight loss) on a scale from 0-2 (S1 Table <ref type="table">)</ref>.</s><s>Clinical GVHD score was assessed by summation of these parameters.</s><s>Animals were sacrificed when exceeding a score of 2 for any one parameter or a score of 6 in total.</s><s>Mice were euthanized by exposure to carbon dioxide.</s><s>No animals died without euthanasia before meeting the humane endpoint criteria.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conditioning, allogeneic stem cell transplantation (allo-BMT) and treatment with EGCG/ Quercetin</head><p><s>Two different murine models were used.</s><s>The major mismatch model C57BL/6!B6D2F1 which has a high and early mortality rate and is used to examine survival and the minor mismatch model LP/J!C57BL/6 which we use to investigate the effects on organs between a control group and a EGCG treated group at day +17.</s><s>Both models have been described previously.</s><s><ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b15">16]</ref> Allo-BMT recipients received a combination of 25mg/kg EGCG (Enzo Life Sciences, Lo ¨rrach, Germany) and 1mg/kg quercetin (Sigma Aldrich) dissolved in DMSO (20μl total) and PBS i.p. daily or EGCG and quercetin alone (for clinical score) or DMSO only (20μl, control) respectively from day 0 to end of experiment.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Evaluation of clinical and histopathological score</head><p><s>Histopathological scores were determined after the Lerner criteria.</s><s><ref type="bibr" target="#b16">[17]</ref> Liver score was dependent on leukocyte infiltration of portal triads (grade I: &lt;25% infiltration, grade II: &lt;50%, grade III: &lt;75%, grade IV: &gt;75%).</s><s>Number of animals per group: N = 10 (clinical score), N = 8 (histopathological score).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunhistochemistry</head><p><s>For analysis of CD4 and CD8 lymphocyte infiltration of GVHD target organs, quantification of Foxp3 positive T cells in the colon and for analysis of neovascularization in liver and colon we used the protocols as described previously.</s><s><ref type="bibr" target="#b15">[16]</ref> Number of animals: N = 8.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Flow cytometry staining</head><p><s>For flow cytometry analyses at day +17 after BMT, peripheral blood, spleen and lymph nodes were harvested as described previously.</s><s><ref type="bibr" target="#b15">[16]</ref> Single cell suspensions were stained with rat antimouse antibodies from BD Biosciences as follows: CD3e-APC-Cy7 (1:100), CD4-PE-Cy7 (1:800), CD8a-APC (1:200), CD25-PerCP-Cy5.5(1:200),</s><s>CD11b-APC-Cy7 (1:400), B220-PerCP-Cy5.5 (1:100) or Nk1.1-PerCP-Cy5.5 <ref type="bibr">(1:200)</ref>.</s><s>For chimerism analysis of blood and BM, antibodies against PE-Ly9.1 (1:100) and FITC-H2kb (1:50) were used.</s><s>Regulatory T cell staining in blood and spleen were performed using Anti-Mouse/Rat FoxP3 Staining Set APC (eBioscience, San Diego, CA, USA) following the manufacturer´s instructions.</s><s>Samples were analyzed by BD FACS Canto II (BD Biosciences) and FlowJo 7.6.5 Software (TreeStar Inc., Ashland, OR, USA).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Glutathione and superoxide dismutase assay</head><p><s>For measuring glutathione in blood, colon and liver at day +17, an assay was performed with the glutathione (GSSG/GSH) detection kit (Enzo Life Sciences, East Farmingdale, NY, USA) after manufacturer´s instructions.</s><s>The superoxide dismutase assay kit from cayman chemical (Ann Arbor, MI, USA) for measuring SOD activity in colon and liver was performed following the manufacturer's instructions.</s><s>Number of animals: N = 8.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistics</head><p><s>Survival data was analyzed using the Kaplan-Meier-method and compared with the Mantel-Cox log-rank test.</s><s>For statistical analysis of all other data the Student´s unpaired t-test was used.</s><s>Values are presented as mean ± s.e.m.</s><s>Values of p 0.05 were considered statistically significant.</s><s>All statistical analyses were performed using GraphPad Prism software (GraphPad Software Inc., La Jolla, CA, USA).</s></p><p><s>Additional information is available under S1 File.</s></p><p><s>Raw data are available under https://osf.io/cznuk/,</s><s>PLOSONE: The green tea catechin Epigallocatechin gallate ameliorates Graft-versus-host disease.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Plasma levels of EGCG can be elevated by quercetin and piperine</head><p><s>Upon uptake, EGCG underlies a rapid chemical transformation (methylation, glucuronidation) reducing its bioavailability.</s><s><ref type="bibr" target="#b17">[18]</ref> To prevent chemical transformation and to enhance bioavailability of EGCG, quercetin or piperine have been used.</s><s>Both substances are known inhibitors of EGCG methylation.</s><s><ref type="bibr" target="#b18">[19,</ref><ref type="bibr" target="#b19">20]</ref> We were interested in the effect of quercetin and piperine on EGCG plasma levels.</s><s>We used a dose of 25mg/kg EGCG, which is based on our previous experiences in animal models of colitis.</s><s><ref type="bibr" target="#b1">[2]</ref> After injection of 25mg/kg EGCG alone or in combination with 1mg/kg quercetin or 1mg/kg piperine we assessed EGCG plasma concentrations (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>Both, the addition of quercetin or piperine increased the peak plasma levels one hour after injection (Fig <ref type="figure" target="#fig_0">1</ref>).</s><s>The mice tolerated the quercetin better than the piperine, we thererfore completed all other experiments using quercetin.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EGCG treatment improves survival and clinical scores of allo-BMT recipients with GVHD</head><p><s>We first studied if a prophylactic treatment with EGCG/quercetin has an impact on the course of lethal GVHD.</s><s>We treated allo-BMT recipients with 25mg/kg EGCG and 1mg/kg quercetin from day 0 to the end of the experiment.</s><s>We found a significantly increased survival rate in EGCG treated allo-BMT recipients vs. non-treated allo-BMT recipients during GVHD (p&lt;0.001) (Fig <ref type="figure" target="#fig_1">2A</ref>).</s><s>In addition, EGCG treated allo-BMT recipients had significantly lower clinical GVHD scores as compared with the control group (p&lt;0.05)</s><s>(Fig <ref type="figure" target="#fig_1">2B</ref>).</s><s>Treatment with 25mg/kg EGCG alone resulted in slightly lower clinical scores without reaching statistical significance.</s><s>When we administered 1mg/kg quercetin alone, we found no effect on GVHD (Fig 2B <ref type="figure">)</ref>, demonstrating that quercetin has no major effects on GVHD in our models.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GVHD related target organ damage is reduced in EGCG treated allo-BMT recipients</head><p><s>To analyze target organ damage we a minor mismatch GVHD model (LP!B6) <ref type="bibr" target="#b15">[16]</ref> and applied histopathological scores after Lerner et al. <ref type="bibr" target="#b16">[17]</ref> At day +17, we found significantly reduced histopathological GVHD scores in liver, colon and skin in EGCG treated allo-BMT recipients vs. controls without EGCG treatment (Fig <ref type="figure" target="#fig_2">3A</ref>).</s><s>In the liver, untreated control allo-</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunomodulatory effects of EGCG in allo-BMT recipients during GVHD</head><p><s>Next, we were interested in possible mechanisms of EGCG-mediated inhibition of GVHD.</s><s>We decided to check three known major effects of EGCG on inflammation: immunomodulation, inhibition of neovascularization and anti-oxidative effects.</s><s>First we investigated immunomodulatory effects.</s><s>We quantified immune cell populations at day +17 after allo-BMT in GVHD target organs using histology.</s><s>We found that the CD8+ population in the colon and the liver was significantly decreased as a result of EGCG treatment (Fig <ref type="figure" target="#fig_3">4A</ref>).</s><s>Interestingly, the CD4+ population was significantly higher in target organs of the EGCG treated allo-BMT recipients vs. controls during GVHD (Fig <ref type="figure" target="#fig_3">4A</ref>).</s><s>Fig 4B shows a representative example of CD4 staining of the colon.</s><s>To further characterize the CD4+ T cells we stained CD4+/FoxP3+ in colon sections.</s><s>We found significantly increased CD4+/FoxP3+ staining in EGCG treated allo-BMT recipients vs. control allo-BMT recipients suggesting higher regulatory T cell (Treg) numbers (Fig <ref type="figure" target="#fig_3">4C</ref>).</s><s>Furthermore we found that numbers of CD3+/CD4+/CD25+/FoxP3+ lymphocytes (Treg) were significantly increased in the blood of the EGCG treated allo-BMT recipients (Fig 4C <ref type="figure">)</ref>, but not in the lymph nodes.</s><s>We conclude that EGCG modulates immune responses during GVHD leading to a higher CD4/CD8 ratio and increased regulatory T cells in the target organs as well as in blood.</s></p><p><s>Additionally we assessed the number of other immune cells found in the blood and the spleen.</s><s>We found no significant differences between EGCG treated and non-treated allo-BMT recipients regarding B cells, NK cells and granulocytes.</s><s>However, the number of CD11b+ monocytes was significantly decreased in the blood of EGCG treated allo-BMT recipients (Fig <ref type="figure" target="#fig_3">4D</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effects of EGCG on oxidative stress during GVHD</head><p><s>Glutathione (GSH) is one of the most important antioxidants it's known to prevent damage to cellular components caused by reactive oxygen species (ROS).</s><s>It is known that when there are increased levels of ROS, glutathione is upregulated.</s><s>We measured the amount of total glutathione and oxidized GSSG (glutathione disulfide) to determine the reduced GSH (total glutathione-oxidized GSSG = reduced GSH) in the blood and in the GVHD target organs colon and liver.</s><s>We found significantly lower amounts of glutathione in the blood of EGCG treated allo- BMT recipients vs. controls during GVHD (Fig <ref type="figure" target="#fig_4">5A</ref>).</s><s>However, we were unable to detect major changes in glutathione concentration in GVHD target organs between EGCG treated allo-BMT recipients vs. controls (Fig 5A <ref type="figure">)</ref>.</s><s>A reason for this result could be that the release of the enzymes during preparation of samples that caused the glutathione to become diminished.</s><s>The activity of glutathione peroxidase (GPO) was significantly increased in the colon in the EGCG treated group, whereas we could not detect any differences in the liver (Fig <ref type="figure" target="#fig_4">5B</ref>).</s><s>In summary, we found signs of diminished oxidative stress during GVHD as a result of EGCG treatment, demonstrated by significant changes of glutathione levels in the blood as well as glutathione peroxidase in the colon.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Impact of EGCG on neovascularization during GVHD</head><p><s>Finally, we were interested if EGCG had effects on GVHD-related neovascularization.</s><s>We harvested tissues in EGCG-treated allo-BMT recipients vs. control allo-BMT recipients at day +17.</s><s>In histological sections we measured the CD31 positive area in liver and colon.</s><s>We observed no significant changes in the liver (control 3,4% CD31 positive area vs. 3,28% after EGCG treatment, p = 0.4).</s><s>In the colon (control 2,64%, EGCG group 2,89%, p = 0.02) changes were significant but very slight.</s><s>We conclude that EGCG has moderate effects on GVHDrelated neovascularization in the colon.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>Our study provides novel evidence demonstrating that EGCG ameliorates lethal GVHD and reduces GVHD-related target organ damage.</s><s>Our results are in line with previous studies demonstrating efficacy of EGCG to inhibit inflammation in vivo.</s><s><ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b20">21]</ref> The use of EGCG in the setting of allo-HSCT is particularly interesting because of its known anti-tumor activity.</s><s>EGCG is effective against a broad spectrum of tumor entities (reviewed in <ref type="bibr" target="#b21">[22]</ref>) like colon cancer, <ref type="bibr" target="#b22">[23]</ref> lung cancer, <ref type="bibr" target="#b23">[24]</ref> and endometrial adenocarcinoma.</s><s><ref type="bibr" target="#b24">[25]</ref> Numerous pathways are involved in tumor growth are affected by EGCG including suppression of NF-κB, <ref type="bibr" target="#b25">[26]</ref> inhibition of phosphoinositide-3-kinase (PI3K), <ref type="bibr" target="#b26">[27]</ref> Akt and STAT3 signaling, <ref type="bibr" target="#b27">[28]</ref> down-regulation of TLR4 signal transduction, activation of 67-kDa laminin receptor (67LR) <ref type="bibr" target="#b28">[29]</ref> and synergistic effects with anticancer drugs and micronutrients.</s><s><ref type="bibr" target="#b29">[30]</ref> Our results contrast a previous study investigating the in vivo use of EGCG in murine GVHD models.</s><s><ref type="bibr" target="#b30">[31]</ref> Choi et al. found only minor effects of EGCG on GVHD when 100μg absolute EGCG was given to allo-BMT recipients twice a day for 21 days.</s><s>Both the survival of the mice and weight development showed no significant differences between control and EGCG treated group neither in a major C57BL/6 into Balb/c mismatch model nor in a minor C57BL/6 into C57BL/6x129 F1 model.</s><s>Our approach had two main differences to that of Choi et al., possibly explaining the distinct results: 1) we co-administered 1mg/kg quercetin to enhance the bioavailability of EGCG, and 2) with 25mg/kg EGCG we applied a higher dose (approximately 500μg vs.100μg EGCG / mouse).</s><s>The dose of EGCG used for murine experiments has a broad range.</s><s>However, in most inflammation mouse models like colitis, arthritis or EAE doses between 10mg/kg and 100mg/kg have been used as a once daily injection.</s><s><ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b31">32,</ref><ref type="bibr" target="#b32">33]</ref> Our results are in line with another publication where donor leukocytes were ex vivo treated with EGCG leading to diminished GVHD in a preclinical model.</s><s><ref type="bibr" target="#b33">[34]</ref> While this approach suggested biological relevance of EGCG for allo-HSCT it has disadvantages: 1) The ex vivo approach may be more difficult to translate into the clinic, and 2) the beneficial effect of EGCG on host tissues, e.g.</s><s>reduction of oxidative stress, are not included.</s></p><p><s>We next investigated the mechanisms by which EGCG mediated reduction of acute GVHD.</s><s>Based on previous knowledge of EGCG effects and on the pathophysiology of inflammatory diseases we were particularly interested in three major areas: 1) immunomodulation, 2) reduction of oxidative stress, and 3) anti-angiogenic effects.</s></p><p><s>First, we studied immunomodulation and we found significant changes including elevated numbers of tissue infiltrating Tregs in EGCG treated allo-BMT recipients during GVHD.</s><s>We believe that this finding may be biologically important because Tregs have previously been demonstrated to be critical factors during GVHD.</s><s>A reduction of regulatory T cells (Tregs) has been described during GVHD <ref type="bibr" target="#b34">[35,</ref><ref type="bibr" target="#b35">36]</ref> and an adoptive transfer of suppression of GVHD without negative impact on tumor growth has been described in pre-clinical models.</s><s><ref type="bibr" target="#b36">[37]</ref> Currently clinical studies on the use of Tregs or substances promoting Tregs as GVHD therapies is ongoing.</s><s>Interestingly, it has been shown that EGCG is able to increase Tregs in vitro and in vivo.</s><s><ref type="bibr" target="#b37">[38]</ref> Recently, it has been described that EGCG increased the secretion of IL-2 in Balb/c mice leading to increased amounts of Tregs in the spleen.</s><s><ref type="bibr" target="#b38">[39]</ref> EGCG also has an influence on different transcription factors leading to modified differentiation of naïve T cells.</s><s>Downregulation of STAT3 and RORγt by EGCG inhibits Th17 differentiation and the suppression of activation of mTOR and subsequently HIF-1α, a metabolic check point of Th17/Treg differentiation leads to increased Treg populations.</s><s><ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b39">40]</ref> Besides, a modified cytokine expression pattern, caused by EGCG, directed to enhance Treg differentiation.</s><s><ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b37">38]</ref> In addition, an in vitro study has been shown that EGCG induced DNMT inhibition facilitates Foxp3 expression in naïve CD4+ T cells resulting in higher amounts of Treg.</s><s><ref type="bibr" target="#b37">[38]</ref> Next, we studied anti-oxidative effects of EGCG during GVHD and found diminished oxidative stress indicated by significant changes of glutathione blood levels as well as increased levels of glutathione peroxidase in the colon.</s><s>It is known that oxidative stress plays a crucial role during inflammation.</s><s><ref type="bibr" target="#b40">[41]</ref> A correlation between oxidative status in the blood and the severity of GVHD has been previously described.</s><s><ref type="bibr" target="#b12">[13]</ref> Glutathione is one of the most important antioxidants, it prevents damage to cells and tissues and it exists in both a reduced (GSH) and oxidized (GSSG) states.</s><s>A dysregulation of GSH could contribute to the development of GVHD, <ref type="bibr" target="#b41">[42]</ref> likewise a detected imbalance of important antioxidative enzymes.</s><s><ref type="bibr" target="#b42">[43]</ref> EGCG is a highly effective antioxidative <ref type="bibr" target="#b43">[44]</ref> that can eliminate reactive oxygen species (ROS).</s><s><ref type="bibr" target="#b44">[45]</ref> Furthermore, EGCG affects the enzyme activity of the antioxidant system like catalase, superoxide dismutase and glutathione peroxidase.</s><s><ref type="bibr" target="#b44">[45]</ref> In our study, we found that EGCG had an effect on the oxidative status as well as on the anti-oxidative enzyme system, which may have contributed to the observed beneficial effects on GVHD.</s></p><p><s>Finally, we were interested in the effect of EGCG on neovascularization after allo-HSCT.</s><s>We have previously demonstrated that GVHD is associated with neovascularization and have identified the inhibition of neovascularization as a therapeutic approach after allo-HSCT.</s><s><ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b9">10]</ref> EGCG is known to mediate anti-angiogenic effects and in different cancer entities administration of EGCG resulted in an inhibition of neovascularization and tumor growth.</s><s><ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b45">46]</ref> In the present study, however, we found only marginal differences in vascular density in colon, but not liver, between EGCG treated allo-BMT recipients and controls.</s><s>We conclude that anti-angiogenic effects are unlikely to be mechanistically relevant for EGCG-mediated regulation of GVHD.</s></p><p><s>In summary, we demonstrate that daily administration of 25mg/kg EGCG in combination with 1mg/kg quercetin ameliorates lethal GVHD in pre-clinical models.</s><s>We found significant immunomodulatory effects, including an increase of regulatory T cells, and a reduction of oxidative stress during GVHD.</s><s>Our results could provide the pre-clinical data for clinical studies investigating the use of EGCG during allo-HSCT.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 .</head><label>1</label><figDesc><div><p><s>Fig 1. Impact of quercetin and piperine on EGCG plasma levels.</s><s>Mice were i.p. injected with 25mg/kg EGCG and 1mg/kg quercetin or 1mg/kg piperine, respectively.</s><s>Blood was taken after 1, 2, 3, 4 and 5 hours and analyzed by LC-MC/MC by Pharmacelsus, Saarbru ¨cken, Germany.</s><s>A typical experiment is shown.</s><s>doi:10.1371/journal.pone.0169630.g001</s></p></div></figDesc><graphic coords="4,36.00,78.01,539.94,245.14" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Impact of EGCG on GVHD-related mortality and clinical GVHD symptoms.</s><s>(a) Impact of EGCG on survival during GVHD.</s><s>2x10 7 BM cells and 5x10 6 T cells from C57BL/6 (H-2K b ) mice were injected into B6D2F1 (H-2K d ) mice after busulfan and cyclophosphamide conditioning (4 days 20mg/kg/day busulfan, 2 days 100mg/kg/day cyclophosphamide).</s><s>Significant differences were seen between EGCG treated and untreated control group (***p&lt;0.001).</s><s>(b) Impact of EGCG on clinical GVHD scores after BMT.</s><s>1,5x10 7 BM and 2x10 6 T cells from LP/J mice were injected into C57BL/6 mice after busulfan and cyclophosphamide conditioning (5 days 20mg/kg/day, 2 days 100mg/kg/day cyclophosphamide).</s><s>EGCG +quercetin treated mice showed significantly decreased GVHD scores compared with control animals.</s><s>N = 10 per group (*p&lt;0.05).</s><s>doi:10.1371/journal.pone.0169630.g002</s></p></div></figDesc><graphic coords="5,36.00,78.01,539.94,193.95" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Impact of EGCG on target organ GVHD.</s><s>1,5x10 7 BM and 2x10 6 T cells from LP/J mice were injected into C57BL/6 mice after busulfan and cyclophosphamide conditioning.</s><s>(a) Histopathological scores in GVHD target organs at day +17.</s><s>H&amp;E-stained sections of colon, liver and skin were analyzed according to Lerner [17].</s><s>Significant differences between EGCG treated and untreated control group in all target organs.</s><s>Data from one representative experiment is shown, N = 8 per group, ***p&lt;0.001.</s><s>(b) Histopathological changes in GVHD target organs at day +17.</s><s>GVHD tissue damage of untreated control group showed in the colon cryptal abscesses (CA) and crypt loss (CL), whereas EGCG treated group showed normal architecture.</s><s>In the liver of the control group excessive lymphoid infiltration (LI) was observed.</s><s>Liver veins of EGCG treated mice showed only minimal infiltrations around the veins.</s><s>Skin of untreated control mice exhibited vacuolization of the epidermis (V), surface damage (SD) and infiltration of immune cells (LI).</s><s>EGCG treated mice showed normal skin structure.</s><s>Original magnification was 200x.</s><s>doi:10.1371/journal.pone.0169630.g003</s></p></div></figDesc><graphic coords="6,36.00,78.01,539.89,306.65" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 4 .</head><label>4</label><figDesc><div><p><s>Fig 4. Impact of EGCG on systemic inflammation during GVHD.</s><s>1,5x10 7 BM and 2x10 6 T cells from LP/J mice were injected into C57BL/6 mice after busulfan and cyclophosphamide conditioning.</s><s>(a) Sections of colon and liver at day +17 were stained with CD4 or CD8 antibody, and at least 6 representative pictures per animal were evaluated.</s><s>CD4 positive cells were increased and CD8 positive cells were decreased as a result of EGCG treatment.</s><s>(b) Representative staining of colon with anti-CD4 antibody.</s><s>Abundant CD4 positive cell infiltration in colon sections of mice treated with EGCG.</s><s>Sections were counterstained with 4', 6-Diamino-2-phenylindole.</s><s>(c) Regulatory T cells during GVHD.</s><s>FACS analysis of blood and lymph nodes and section analysis of colon of mice treated or nontreated with EGCG.</s><s>Tregs were increased in blood and colon of EGCG treated mice.</s><s>(d) Leukocytes during GVHD.</s><s>FACS analysis of blood and spleens of myeloid and lymphoid cells during GVHD.</s><s>Within analyzed cells (B cells, monocytes, granulocytes and NK cells), monocytes were significantly decreased in the blood of EGCG treated mice.</s><s>Shown is data from one representative experiment, n = 8 (ns = not significant, *p &lt;0.05, **p&lt;0.01</s><s>***p&lt;0.001).</s><s>doi:10.1371/journal.pone.0169630.g004</s></p></div></figDesc><graphic coords="7,36.00,78.01,539.94,320.71" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig 5 .</head><label>5</label><figDesc><div><p><s>Fig 5. Impact of EGCG on oxidative stress during GVHD.</s><s>(a) Glutathione levels during GVHD.</s><s>Glutahione (GSH) was measured in blood, colon and the liver of EGCG treated and untreated allo-BMT recipients at day +17.</s><s>A significantly decreased amount of glutathione in the blood was observed after treatment with EGCG.</s><s>(b) GPO amounts in the colon and liver during GVHD.</s><s>Sections of colon and liver at day +17 were stained with GPO antibody, and at least 6 representative pictures per animal were evaluated.</s><s>A significantly decreased amount of glutathione peroxidase in the colon but not in the liver was observed after treatment with EGCG.</s><s>n = 8 (ns = not significant, *p &lt;0.05, **p&lt;0.01,</s><s>***p&lt;0.001).</s><s>doi:10.1371/journal.pone.0169630.g005</s></p></div></figDesc><graphic coords="8,36.00,78.01,539.94,145.25" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | DOI:10.1371/journal.pone.0169630 January 19, 2017</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" />			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">The chemistry of tea flavonoids. Critical reviews in food science and nutrition</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Balentine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Wiseman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Bouwens</surname></persName>
		</author>
		<idno type="DOI">10.1080/10408399709527797</idno>
		<idno type="PMID">9447270</idno>
		<imprint>
			<date type="published" when="1997">1997</date>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="693" to="704" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Green tea polyphenol epigallocatechin-3-gallate shows therapeutic antioxidative effects in a murine model of colitis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bruckner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Westphal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Domschke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kucharzik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lugering</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Crohn&apos;s &amp; colitis</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="226" to="235" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Molecular nutrition &amp; food research</title>
		<author>
			<persName><forename type="first">M</forename><surname>Friedman</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="116" to="134" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The potential role of green tea catechins in the prevention of the metabolic syndrome-a review</title>
		<author>
			<persName><forename type="first">F</forename><surname>Thielecke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boschmann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.phytochem.2008.11.011</idno>
		<idno type="PMID">19147161</idno>
	</analytic>
	<monogr>
		<title level="j">Phytochemistry</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="24" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Green tea and green tea catechin extracts: an overview of the clinical evidence</title>
		<author>
			<persName><forename type="first">R</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bryant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Huntley</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.maturitas.2012.08.008</idno>
		<idno type="PMID">22986087</idno>
	</analytic>
	<monogr>
		<title level="j">Maturitas</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="280" to="287" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">CD4+CD25+ regulatory T cells and graft-versus-host disease</title>
		<author>
			<persName><forename type="first">P</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Edinger</surname></persName>
		</author>
		<idno type="DOI">10.1053/j.seminhematol.2005.09.006</idno>
		<idno type="PMID">16412790</idno>
	</analytic>
	<monogr>
		<title level="j">Seminars in hematology</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="62" to="69" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main">Epigallocatechin-3-gallate ameliorates experimental autoimmune encephalomyelitis by altering balance among CD4+ T-cell subsets. The American journal of pathology</title>
		<author>
			<persName><forename type="first">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Xiao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Meydani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Wu</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ajpath.2011.09.007</idno>
		<idno type="PMID">22056360</idno>
		<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="221" to="234" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1alpha with Th17/Treg control</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">M</forename><surname>Moon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">O</forename><surname>Jung</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0086062</idno>
		<idno type="PMID">24558360</idno>
		<idno type="PMCID">PMC3928092</idno>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e86062</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="report_type">PubMed Central</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth</title>
		<author>
			<persName><forename type="first">O</forename><surname>Penack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Henke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Suh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Na</surname></persName>
		</author>
		<idno type="DOI">10.1093/jnci/djq172</idno>
		<idno type="PMID">20463307</idno>
		<idno type="PMCID">PMC2886094</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the National Cancer Institute</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="894" to="908" />
			<date type="published" when="2010-05-14">2010. 2010/05/14</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The importance of neovascularization and its inhibition for allogeneic hematopoietic stem cell transplantation</title>
		<author>
			<persName><forename type="first">O</forename><surname>Penack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Socie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Van Den Brink</surname></persName>
		</author>
		<idno type="DOI">10.1182/blood-2010-10-312934</idno>
		<idno type="PMID">21258010</idno>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="4181" to="4189" />
			<date type="published" when="2011-01-25">2011. 2011/01/25</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<monogr>
		<title level="m" type="main">Inhibitory effects of epigallocatechin-3 gallate, a polyphenol in green tea, on tumor-associated endothelial cells and endothelial progenitor cells. Cancer science</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ohga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Muraki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tsuchiya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matsuda</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1349-7006.2009.01255.x</idno>
		<idno type="PMID">19650861</idno>
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="1963" to="1970" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Dona</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Dell'aica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Calabrese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Benelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Morini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Albini</surname></persName>
		</author>
		<idno type="PMID">12682270</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="4335" to="4341" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">The oxidative status of blood cells in a murine model of graft-versus-host disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Amer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Reich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Shapira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Slavin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fibach</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00277-007-0321-7</idno>
		<idno type="PMID">17653715</idno>
	</analytic>
	<monogr>
		<title level="j">Annals of hematology</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="753" to="758" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Effects of melatonin treatment in septic newborns</title>
		<author>
			<persName><forename type="first">E</forename><surname>Gitto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karbownik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Reiter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">X</forename><surname>Tan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Cuzzocrea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chiurazzi</surname></persName>
		</author>
		<idno type="DOI">10.1203/00006450-200112000-00021</idno>
		<idno type="PMID">11726736</idno>
	</analytic>
	<monogr>
		<title level="j">Pediatric research</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="756" to="760" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells. Molecular vision</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Cavet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Vollmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Z</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="PMID">21364905</idno>
		<idno type="PMCID">PMC3044696</idno>
		<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="533" to="542" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<monogr>
		<title level="m" type="main">A preclinical acute GVHD mouse model based on chemotherapy conditioning and MHC-matched transplantation. Bone marrow transplantation</title>
		<author>
			<persName><forename type="first">K</forename><surname>Riesner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kalupa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Elezkurtaj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Penack</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<monogr>
		<title level="m" type="main">Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors. Transplantation proceedings</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Lerner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">F</forename><surname>Kao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Storb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Buckner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Clift</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Thomas</surname></persName>
		</author>
		<idno type="PMID">4155153</idno>
		<imprint>
			<date type="published" when="1974">1974</date>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="367" to="371" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<monogr>
		<title level="m" type="main">Bioavailability issues in studying the health effects of plant polyphenolic compounds. Molecular nutrition &amp; food research</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="S139" to="S151" />
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Quercetin increased bioavailability and decreased methylation of green tea polyphenols in vitro and in vivo</title>
		<author>
			<persName><forename type="first">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Heber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Henning</surname></persName>
		</author>
		<idno type="PMCID">PMC3590855</idno>
	</analytic>
	<monogr>
		<title level="j">Food &amp; function</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="635" to="642" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Piperine enhances the bioavailability of the tea polyphenol (-)-epigallocatechin-3-gallate in mice</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Lambert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Mishin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Yang</surname></persName>
		</author>
		<idno type="PMID">15284381</idno>
	</analytic>
	<monogr>
		<title level="j">The Journal of nutrition</title>
		<imprint>
			<biblScope unit="volume">134</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1948" to="1952" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Green tea polyphenol epigallocatechin-3-gallate: inflammation and arthritis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Akhtar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Haqqi</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.lfs.2010.04.013</idno>
		<idno type="PMID">20462508</idno>
		<idno type="PMCID">PMC3146294</idno>
	</analytic>
	<monogr>
		<title level="j">Life sciences</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="907" to="918" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Green tea polyphenols and their potential role in health and disease</title>
		<author>
			<persName><forename type="first">M</forename><surname>Afzal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Safer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Menon</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10787-015-0236-1</idno>
		<idno type="PMID">26164000</idno>
	</analytic>
	<monogr>
		<title level="j">Inflammopharmacology</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="151" to="161" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<monogr>
		<title level="m" type="main">Implication of Akt, ERK1/2 and alternative p38MAPK signalling pathways in human colon cancer cell apoptosis induced by green tea EGCG. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Cerezo-Guisado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Zur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Lorenzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Risco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Martin-Serrano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Alvarez-Barrientos</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="125" to="132" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Epigallocatechin gallate inhibits the growth of human lung cancer by directly targeting the EGFR signaling pathway</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">B</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">X</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.3892/or.2013.2933</idno>
		<idno type="PMID">24366444</idno>
	</analytic>
	<monogr>
		<title level="j">Oncology reports</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="1343" to="1349" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Regulation of Vascular Endothelial Growth Factor in endometrial tumour cells by resveratrol and EGCG</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Dann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Sykes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Mason</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Evans</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ygyno.2009.02.014</idno>
		<idno type="PMID">19321194</idno>
	</analytic>
	<monogr>
		<title level="j">Gynecologic oncology</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="374" to="378" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Natural polyphenols that display anticancer properties through inhibition of kinase activity</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lamoral-Theys</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pottier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Dufrasne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Neve</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Dubois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kornienko</surname></persName>
		</author>
		<idno type="PMID">20156174</idno>
	</analytic>
	<monogr>
		<title level="j">Current medicinal chemistry</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="812" to="825" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<monogr>
		<title level="m" type="main">Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochemical and biophysical research communications</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Van Aller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Carson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Copeland</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bbrc.2011.02.010</idno>
		<idno type="PMID">21300025</idno>
		<imprint>
			<date type="published" when="2011">2011</date>
			<biblScope unit="volume">406</biblScope>
			<biblScope unit="page" from="194" to="199" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Mechanism of the inhibition of the STAT3 signaling pathway by EGCG</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Deng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Yan</forename><forename type="middle">E</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
		<idno type="DOI">10.3892/or.2013.2743</idno>
		<idno type="PMID">24065300</idno>
	</analytic>
	<monogr>
		<title level="j">Oncology reports</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="2691" to="2696" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">TLR4 signaling inhibitory pathway induced by green tea polyphenol epigallocatechin-3-gallate through 67-kDa laminin receptor</title>
		<author>
			<persName><forename type="first">Hong</forename><surname>Byun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fujimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tachibana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
		<idno type="DOI">10.4049/jimmunol.0903742</idno>
		<idno type="PMID">20511545</idno>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">185</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="45" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Micronutrient synergy-a new tool in effective control of metastasis and other key mechanisms of cancer</title>
		<author>
			<persName><forename type="first">A</forename><surname>Niedzwiecki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Roomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kalinovsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rath</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10555-010-9244-1</idno>
		<idno type="PMID">20717705</idno>
		<idno type="PMCID">PMC2933847</idno>
	</analytic>
	<monogr>
		<title level="j">Cancer metastasis reviews</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="529" to="542" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Effect of epigallocatechin-3-gallate on graft-versus-host disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Choi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">D</forename><surname>Ziga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ritchey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Dipersio</surname></persName>
		</author>
		<idno type="DOI">10.3727/096368913X667691</idno>
		<idno type="PMID">23676554</idno>
	</analytic>
	<monogr>
		<title level="j">Cell Transplant</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1163" to="1166" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-kappaB and Nrf2/HO-1 Signalling Pathway Regulation</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Su</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Basic &amp; clinical pharmacology &amp; toxicology</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="164" to="172" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Abboud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Hake</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Burroughs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Odoms</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Connor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mangeshkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.ejphar.2007.10.053</idno>
		<idno type="PMID">18022615</idno>
	</analytic>
	<monogr>
		<title level="j">European journal of pharmacology</title>
		<imprint>
			<biblScope unit="volume">579</biblScope>
			<biblScope unit="issue">1-3</biblScope>
			<biblScope unit="page" from="411" to="417" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Attenuation of murine graft-versus-host disease by a tea polyphenol</title>
		<author>
			<persName><forename type="first">J</forename><surname>Kanamune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Iwanaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Noguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Matsumura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Uemoto</surname></persName>
		</author>
		<idno type="DOI">10.3727/096368911X623934</idno>
		<idno type="PMID">22330060</idno>
	</analytic>
	<monogr>
		<title level="j">Cell transplantation</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="909" to="918" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease</title>
		<author>
			<persName><forename type="first">K</forename><surname>Matsuoka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Koreth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bascug</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mcdonough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kawano</surname></persName>
		</author>
		<idno type="DOI">10.1126/scitranslmed.3005265</idno>
		<idno type="PMID">23552371</idno>
		<idno type="PMCID">PMC3686517</idno>
	</analytic>
	<monogr>
		<title level="j">Sci Transl Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="issue">179</biblScope>
			<date type="published" when="2013-04-05">2013. 2013/04/05</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<monogr>
		<title level="m" type="main">Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Alho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Chammas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Matos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Forcade</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation</title>
		<author>
			<persName><forename type="first">M</forename><surname>Edinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Drago</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Fathman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Strober</surname></persName>
		</author>
		<idno type="DOI">10.1038/nm915</idno>
		<idno type="PMID">12925844</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1144" to="1150" />
			<date type="published" when="2003-08-20">2003. 2003/08/20</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Induction of regulatory T cells by green tea polyphenol EGCG</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Noh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Bray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Bruno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ho</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.imlet.2011.04.009</idno>
		<idno type="PMID">21621552</idno>
		<idno type="PMCID">PMC4125122</idno>
	</analytic>
	<monogr>
		<title level="j">Immunology letters</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="issue">1-2</biblScope>
			<biblScope unit="page" from="7" to="13" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Immunomodulatory effects of EGCG fraction of green tea extract in innate and adaptive immunity via T regulatory cells in murine model</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Liou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hsieh</surname></persName>
		</author>
		<idno type="DOI">10.3109/08923973.2014.953637</idno>
		<idno type="PMID">25151997</idno>
	</analytic>
	<monogr>
		<title level="j">Immunopharmacology and immunotoxicology</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="364" to="370" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Green tea EGCG, T cells, and T cell-mediated autoimmune diseases</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">Y</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Pae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Meydani</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.mam.2011.10.001</idno>
		<idno type="PMID">22020144</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Aspects Med</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="107" to="118" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title level="m" type="main">Linkage of inflammation and oxidative stress via release of glutathionylated peroxiredoxin-2, which acts as a danger signal. Proceedings of the National Academy of Sciences of the United States of America</title>
		<author>
			<persName><forename type="first">S</forename><surname>Salzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Checconi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Hanschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Lillig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Bowler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chan</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.1401712111</idno>
		<idno type="PMID">25097261</idno>
		<idno type="PMCID">PMC4143057</idno>
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="12157" to="12162" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Thiol/redox metabolomic profiling implicates GSH dysregulation in early experimental graft versus host disease (GVHD)</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Suh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kanathezhath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shenvi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tiwana</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0088868</idno>
		<idno type="PMID">24558439</idno>
		<idno type="PMCID">PMC3928313</idno>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">e88868</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<monogr>
		<title level="m" type="main">Disturbance of pro-oxidative/antioxidative balance in allogeneic peripheral blood stem cell transplantation. Annals of clinical and laboratory science</title>
		<author>
			<persName><forename type="first">I</forename><surname>Sari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cetin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kaynar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Saraymen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Hacioglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ozturk</surname></persName>
		</author>
		<idno type="PMID">18469356</idno>
		<imprint>
			<date type="published" when="2008">2008</date>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="120" to="125" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shankar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Srivastava</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.bcp.2011.07.093</idno>
		<idno type="PMID">21827739</idno>
		<idno type="PMCID">PMC4082721</idno>
	</analytic>
	<monogr>
		<title level="j">Biochemical pharmacology</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1807" to="1821" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Tea and cancer</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">Y</forename><surname>Wang</surname></persName>
		</author>
		<idno type="PMID">8515490</idno>
	</analytic>
	<monogr>
		<title level="j">Journal of the National Cancer Institute</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="issue">13</biblScope>
			<biblScope unit="page" from="1038" to="1049" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo</title>
		<author>
			<persName><forename type="first">H</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Becker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Lui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Chu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">N</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Kung</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.fertnstert.2011.07.008</idno>
		<idno type="PMID">21821246</idno>
	</analytic>
	<monogr>
		<title level="j">Fertility and sterility</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1021" to="1028" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
